[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75590]], camposKey:0006-4971 2023-01-26 Novel variants in GALE cause syndromic macrothrombocytopenia by disrupting glycosylation and thrombopoiesis406421, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75591]], camposKey:2077-0383 2022-06-01 Full Characterization of Thrombotic Events in All Hospitalized COVID-19 Patients in a Spanish Tertiary Hospital during the First 18 Months of the Pandemic00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75592]], camposKey:2296-858X 2022-04-25 ABO Blood System and COVID-19 Susceptibility: Anti-A and Anti-B Antibodies Are the Key Points00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75593]], camposKey:0732-183X 2022-01-20 Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA)242251, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75594]], camposKey:2284-2594 2022-01-01 Fibrinogen Deficiency with Thrombotic Manifestations00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65938]], camposKey:1664-3224 2021-10-13 Can the Cytokine Profile According to ABO Blood Groups Be Related to Worse Outcome in COVID-19 Patients? Yes, They Can00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=74163]], camposKey:2075-4426 2021-07-01 Evaluation of cytokines as robust diagnostic biomarkers for COVID-19 detection00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=83203]], camposKey:2077-0383 2021-05-01 HGF, IL-1¿, and IL-27 are robust biomarkers in early severity stratification of COVID-19 patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66945]], camposKey:0006-4971 2021-04-08 Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome¿negative adult lymphoblastic leukemia18791894, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=76541]], camposKey:2077-0383 2021-01-01 Predictive modeling of poor outcome in severe covid-19: A single-center observational study based on clinical, cytokine and laboratory profiles00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66946]], camposKey:0939-5555 2020-04-01 RELINF: prospective epidemiological registry of lymphoid neoplasms in Spain. A project from the GELTAMO group799808, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61691]], camposKey:1664-2295 2020-01-01 Neurological Comorbidity Is a Predictor of Death in Covid-19 Disease: A Cohort Study on 576 Patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52143]], camposKey:0902-4441 2020-01-01 Use of eltrombopag for patients 65 years old or older with immune thrombocytopenia259270, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47734]], camposKey:0019-9567 2018-01-01 Polymorphisms in receptors involved in opsonic and nonopsonic phagocytosis, and correlation with risk of infection in oncohematology patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47736]], camposKey:0925-5710 2017-01-01 Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practice508516, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47739]], camposKey:0902-4441 2016-09-01 Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice297302, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47745]], camposKey:0361-8609 2015-01-01 Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68838]], camposKey:0902-4441 2014-11-01 Genomic analysis of clonal eosinophils by CGH arrays reveals new genetic regions involved in chronic eosinophilia422428, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22426]], camposKey:0210-5705 2014-01-01 Linfoma MALT y tumor carcinoide sincrónicos de íleon9596, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56309]], camposKey:0210-5705 2014-01-01 Synchronic MALT lymphoma and carcinoid tumor of the ileum Linfoma MALT y tumor carcinoide sincrónicos de íleon9596, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22427]], camposKey:0210-6523 2013-01-01 Linfoma de Hodgkin259271, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68846]], camposKey:0390-6078 2010-05-01 Long FLT3 internal tandem duplications and reduced PML-RAR¿ expression at diagnosis characterize a high-risk subgroup of acute promyelocytic leukemia patients745751, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68849]], camposKey:0145-2126 2009-12-01 High FOXO3a expression is associated with a poorer prognosis in AML with normal cytogenetics17061709, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47750]], camposKey:0145-2126 2009-06-01 Hematologic and cytogenetic response to lenalidomide in de novo acute myeloid leukemia with chromosome 5q deletion00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68852]], camposKey:0006-4971 2009-01-01 Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia148152, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68150]], camposKey:1130-0108 2008-08-01 Jejunal mucormycosis in a patient with Hodgkin's lymphoma Mucormicosis yeyunal en paciente con linfoma de Hodgkin507510, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22429]], camposKey:0210-6523 2008-01-01 Nuevas perspectivas en el tratamiento y curación de las leucemias275288, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47753]], camposKey:0929-5305 2006-01-01 Oral anticoagulant treatment: Risk factors involved in 500 intracranial hemorrhages113120, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47755]], camposKey:1130-0108 2005-09-01 Primary biliary cirrhosis, "sicca" syndrome and autoimmune hemolytic anemia [5] Cirrosis biliar primaria, síndrome "sicca" y anemia hemolítica autoinmune678679, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=22428]], camposKey:0210-6523 2005-01-01 Tratamiento del mieloma múltiple con trasplante autólogo de progenitores hematopoyéticos93109, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38347]], camposKey:0009-7330 2004-01-01 Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction742748, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47713]], camposKey:0300-8932 2004-01-01 Intracoronary stem cell transplantation in acute myocardial infarction Regeneración miocárdica mediante la implantación intracoronaria de células madre en el infarto agudo de miocardio201208, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=14434]], camposKey:0300-8932 2004-01-01 Regeneración miocárdica mediante la implantación intracoronaria de células madre en el infarto agudo de miocardio201208, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47758]], camposKey:1466-4860 2003-08-11 Emphysematous gastritis and severe aplastic anemia8284][][][][][][][][][][][com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=30936]]][][][][][][][][][][com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8758, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8b7d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8387, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f825b, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f917d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f97c6, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8d77, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f90ab][][][][][][][][][][][][][][][]